Meeting
2018 ASCO Annual Meeting
Effect of therapeutic pressure on stability of EGFR amplification in glioblastoma.
Authors
Manmeet Singh Ahluwalia
Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH
Manmeet Singh Ahluwalia , Cara R. Dimino , Mahesh M. Mansukhani , Vundavalli V. Murty , Peter Canoll , Yoshitaka Narita , Yoshihiro Muragaki , Hui Kong Gan , Ryan Thomas Merrell , Martin J. Van Den Bent , Zheng Zha , Lisa Roberts-Rapp , Fang Jiang , Maria Guseva , Earle E. Bain , Christopher Joseph Ocampo , Peter J Ansell , Andrew B. Lassman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 36, 2018 (suppl; abstr 2033)
DOI
10.1200/JCO.2018.36.15_suppl.2033
Abstract #
2033
Poster Bd #
191
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
Clinical use of personalized molecular biomarkers in patients with glioblastoma.
First Author: M. Holdhoff
First Author: Fontanilles Maxime
Poster
2022 ASCO Annual Meeting
Identifying biomarkers associated with disease-free survival in stage I non–small cell lung cancer.
First Author: Christopher W. Seder
Poster
2014 ASCO Annual Meeting
GEINO-11: A prospective multicenter, open label, phase II pilot clinical trial to evaluate safety and efficacy of PF-299804 (dacomitinib), a pan-HER irreversible inhibitor, in patients with recurrent glioblastoma with EGFR amplification or presence of EGFRvIII mutation.
First Author: Juan Manuel Sepúlveda